Vertex News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

23.12.24	Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst (Benzinga)
22.12.24	Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025? (MotleyFool)
19.12.24	Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data? (Benzinga)
09.12.24	Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock (Benzinga)
09.12.24	Decoding 9 Analyst Evaluations For Vertex (Benzinga)
09.12.24	A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts (Benzinga)
04.12.24	FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program (Benzinga)
25.11.24	Looking Into Vertex Pharmaceuticals's Recent Short Interest (Benzinga)
18.11.24	A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics (Benzinga)
07.11.24	Critical Insights From Vertex Analyst Ratings: What You Need To Know (Benzinga)
07.11.24	Vertex Analysts Increase Their Forecasts Following Strong Q3 Results (Benzinga)
05.11.24	Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity (Benzinga)
05.11.24	Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts (Benzinga)
05.11.24	Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript (MotleyFool)
04.11.24	Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts? (Benzinga)
28.10.24	Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years (Benzinga)
24.10.24	Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits (MotleyFool)
21.10.24	Looking Into Vertex Pharmaceuticals's Recent Short Interest (Benzinga)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V